Loss of TACC1 variant25 inducing cell proliferation and suppressing autophagy in head and neck squamous carcinoma

Pan Xu1,2,3,4,5, Ran Zhao1,2,3,4,5, Chen-Yang Zhang1

  • 1Department of Oral Mucosal Diseases, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Cell Death Discovery
|December 13, 2021
PubMed

Insights

Transforming acidic coiled-coil containing protein1 variant25 (TACC1v25) is downregulated in head and neck squamous cell carcinoma. TACC1v25 inhibits cancer progression by reducing proliferation and increasing autophagy via the ERK and AKT/mTOR pathways.

Area of Science:

  • Molecular oncology
  • Cellular biology
  • Cancer research

Background:

  • Transforming acidic coiled-coil containing protein1 (TACC1) plays roles in transcription, translation, and centrosome dynamics.
  • TACC1 dysregulation is linked to various cancers, with alternative splicing producing significant variants.
  • The specific roles of TACC1 variants in head and neck squamous cell carcinoma (HNSCC) are not well understood.

Purpose of the Study:

  • To investigate the expression patterns and biological functions of TACC1 variants in HNSCC.
  • To determine the specific role of TACC1 variant25 (TACC1v25) in HNSCC progression.
  • To elucidate the molecular mechanisms underlying TACC1v25's effects in HNSCC.

Main Methods:

  • Analysis of TACC1 variant expression in HNSCC tissues and cell lines.
  • Overexpression of TACC1v25 in HNSCC cell lines (Cal27 and Fadu).
  • Assessment of cell proliferation, autophagy markers (Beclin-1, LC3II/LC3I ratio), and signaling pathways (pERK, p-mTOR, AKT).

Main Results:

  • TACC1 variants show a distinct expression pattern in HNSCC.
  • TACC1v25 is significantly downregulated in HNSCC tissues and cell lines.
  • Overexpression of TACC1v25 suppressed proliferation and enhanced autophagy in HNSCC cells.
  • TACC1v25 overexpression led to decreased nuclear pERK and p-mTOR, and increased Beclin-1 and LC3II/LC3I ratio.
  • Autophagy was rescued by activating the AKT pathway with SC79.

Conclusions:

  • TACC1v25 inhibits HNSCC progression by reducing proliferation and promoting autophagy.
  • The tumor-suppressive effects of TACC1v25 are mediated through the ERK and AKT/mTOR signaling pathways.
  • TACC1v25 demonstrates potential as a therapeutic target or tumor suppressor in HNSCC.

Related Concept Videos

Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
5.2K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.2K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.3K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.7K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
3.8K